Research & Development



  接下來的時間,是劉徹大展拳腳的空間,也是大漢國向外擴張的黃金時期。 大香蕉伊人久草av   劉據愣了片刻,終于慢慢的道︰“我不是不喜歡外戚,你看,我跟我舅舅家的三個兒子關系就很好。我只是不喜歡,霍去病,不喜歡雲瑯……我是太子,是天生的未來皇帝,既然我是太子,他們就該事事以我為先。可是,他們都很驕傲,需要去求他們,我實在是彎不下這個腰!”伊人在线大香蕉网4久草   不一會,兩人又分別走了進來,李息看看雲瑯,就閉上眼楮一言不發,當起了石翁仲。   他喜歡這個!大香蕉网伊人在线   雲瑯冷笑道︰“當你的先生會折壽,這兩個字還是少說為妙。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo